<DOC>
	<DOCNO>NCT00404716</DOCNO>
	<brief_summary>Cilostazol kind oral antiplatelet agent rapid onset action selectively inhibit phosphodiesterase III , mechanism different adenosine diphosphate ( ADP ) receptor antagonist . Previous study suggest cilostazol lipid-modifying vasodilating effect addition antiplatelet effect . From experimental clinical background , assume triple antiplatelet therapy aspirin , clopidogrel , cilostazol might beneficial effect prevention atherothrombosis complication follow coronary stenting . Therefore , evaluate safety efficacy triple antiplatelet regimen aspirin , clopidogrel cilostazol compare dual antiplatelet regimen aspirin clopidogrel patient acute coronary syndrome undergo successful coronary artery stenting . Patients undergo successful coronary stenting divide dual antiplatelet therapy ( aspirin plus clopidogrel ) triple antiplatelet therapy ( aspirin clopidogrel plus cilostazol ) group . All enrol patient triple regimen group receive cilostazol 100mg , b.i.d. , 6 month addition standard dose duration aspirin clopidogrel post-PCI . The primary endpoint include death , myocardial infarction , target lesion revascularization , stent thrombosis within 30 day , binary restenosis six month major adverse cardiac event ( MACE ) one year . The secondary endpoint side effect study drug , include major bleeding , vascular complication , hypersensitivebility , bleed complication . The study power test hypothesis triple antiplatelet therapy well dual antiplatelet therapy .</brief_summary>
	<brief_title>Triple Versus Dual Antiplatelet Therapy Patients Undergoing Coronary Stent Implantation</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Diagnosed ACS Undergoing coronary stent implantation Between age 18 Years bellow 80 Years . Presence one several stenosis native coronary artery require PCI . Willing able sign inform consent . A history bleed diathesis . New York Heart Association functional class IV . Prior PCI coronary bypass graft &lt; 3 month . Contraindications clopidogrel aspirin ( White blood cell count &lt; 4×109/L platelet count &lt; 100 g.l1 ; creatinine clearance &lt; 25 ml • min1 ; active liver disease ) . Use glycoprotein IIb/IIIa inhibitor PCI . Preparing undergo CABG Taken clopidogrel cilostazol recently</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>